TipRanks
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
GLSI
Greenwich LifeSciences
RESEARCH TOOLSreports

Greenwich LifeSciences (GLSI) Income Statement

450 Followers

Greenwich LifeSciences Income Statement

Last quarter (Q2 2026), Greenwich LifeSciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Greenwich LifeSciences's net income was $-3.95M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.78K$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Expenses
$ 19.45M$ 17.63M$ 9.32M$ 8.04M$ 4.59M
Depreciation and Amortization
$ 1.78K$ 3.61K$ 3.61K$ 3.61K$ 3.61K
EBITDA
$ -19.36M$ -17.41M$ -8.89M$ -7.82M$ -4.57M
Operating Income
$ -19.45M$ -17.64M$ -9.33M$ -8.04M$ -4.60M
Other Income/Expenses
$ 89.70K$ 223.01K$ 436.06K$ 215.02K$ 27.37K
Pretax Income
$ -19.36M$ -17.41M$ -8.89M$ -7.83M$ -4.57M
Net Income
$ -19.36M$ -17.41M$ -8.89M$ -7.83M$ -4.57M
Per Share Metrics
Basic EPS
$ -1.43$ -1.21$ -0.69$ -0.61$ -0.35
Diluted EPS
$ -1.43$ -1.21$ -0.69$ -0.61$ -0.35
Weighted Average Shares Outstanding
 13.53M 13.01M 12.85M 12.91M 12.94M
Weighted Average Shares Outstanding (Diluted)
 13.53M 13.01M 12.85M 12.91M 12.94M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History